Latest advances in intracerebral hemorrhage

Current Neurology and Neuroscience Reports

Volumn 6, Issue 1, 2006, Pages 17-22

  Ribo, Marc ^b   Grotta, James C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN E; ARGATROBAN; FIBRONECTIN; GELATINASE B; ILOMASTAT; IRON; MACROPHAGE MIGRATION INHIBITION FACTOR; MANNITOL; MEMANTINE; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ALCOHOL CONSUMPTION; AMINOTRANSFERASE BLOOD LEVEL; BLOOD VESSEL INJURY; BRAIN DAMAGE; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORRELATION ANALYSIS; CRANIOTOMY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME INHIBITION; GLASGOW COMA SCALE; HUMAN; HYPERTENSION; INCIDENCE; MENOPAUSE; MORBIDITY; MORTALITY; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIMARY PREVENTION; PROGNOSIS; REVIEW; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SMOKING; SYSTEMATIC REVIEW; THROMBOEMBOLISM; TREATMENT OUTCOME; TREATMENT RESPONSE; UMBILICAL CORD BLOOD; VASCULAR AMYLOIDOSIS;

ANIMALS; BRAIN; CEREBRAL HEMORRHAGE; FACTOR VII; HUMANS; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; RECOMBINANT PROTEINS;

EID: 31444457144     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-996-0004-0     Document Type: Review

References (32)

1. Priorities for clinical research in intracerebral hemorrhage: report from a national institute of neurological disorders and stroke workshop. Stroke 2005, 36:e23-e41.
2. Feldmann E, Broderick JP, Kernan WN, et al.: Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke 2005, 36:1881-1885.
3. Kim HC, Kang DR, Nam CM, et al.: Elevated serum aminotransferase level as a predictor of intracerebral hemorrhage: Korea medical insurance corporation study. Stroke 2005, 36:1642-1647.
4. Van Guelpen B, Hultdin J, Johansson I, et al.: Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: a prospective, nested case-referent study of plasma concentrations and dietary intake. Stroke 2005, 36:1426-1431.
5. Woo D, Kaushal R, Chakraborty R, et al.: Association of apolipoprotein e4 and haplotypes of the apolipoprotein e gene with lobar intracerebral hemorrhage. Stroke 2005, 36:1874-1879.
6. Passero SG, Calchetti B, Bartalini S: Intracranial bleeding in patients with vertebrobasilar dolichoectasia. Stroke 2005, 36:1421-1425.
7. Brott T, Broderick J, Kothari R, et al.: Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997, 28:1-5.
8. Fuji Y, Takeuchi S, Sasaki O, et al.: Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998, 29:1160-1166.
9. Fujitsu K, Muramoto M, Ikeda Y, et al.: Indications for surgical treatment of putaminal hemorrhage. Comparative study based on serial CT and time-course analysis. J Neurosurg 1990, 73:518-525.
10. Kazui S, Naritomi H, Yamamoto H, et al.: Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 1996, 27:1783-1787.
11. Silva Y, Leira R, Tejada J, et al.: Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 2005, 36:86-91.
12. Orakcioglu B, Fiebach JB, Steiner T, et al.: Evolution of early perihemorrhagic changes - ischemia vs. Edema: an MRI study in rats. Exp Neurol 2005, 193:369-376.
13. Huang FP, Xi G, Keep RF, et al.: Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg 2002, 96:287-293.
14. Chiueh CC: Iron overload, oxidative stress, and axonal dystrophy in brain disorders. Pediatr Neurol 2001, 25:138-147.
15. Shao J, Xi G, Hua Y, et al.: Intracerebral hemorrhage in the iron-deficient rat. Stroke 2005, 36:660-664.
16. Nakamura T, Xi G, Park JW, et al.: Holo-transferrin and thrombin can interact to cause brain damage. Stroke 2005, 36:348-352.
17. Nagatsuna T, Nomura S, Suehiro E, et al.: Systemic administration of argatroban reduces secondary brain damage in a rat model of intracerebral hemorrhage: histopathological assessment. Cerebrovasc Dis 2005, 19:192-200.
18. Abilleira S, Montaner J, Molina CA, et al.: Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. J Neurosurg 2003, 99:65-70.
19. Alvarez-Sabin J, Delgado P, Abilleira S, et al.: Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: Relationship to clinical and radiological outcome. Stroke 2004, 35:1316-1322.
20. Lee JM, Yin K, Hsin I, et al.: Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage. J Neurol Sci 2005, 230:249-254.
21. Wang J, Tsirka SE: Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain 2005, 128:1622-1633.
22. Ritter MA, Droste DW, Hegedus K, et al.: Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients. Neurology 2005, 64:1233-1237.
23. Lu A, Tang Y, Ran R, et al.: Brain genomics of intracerebral hemorrhage. J Cereb Blood Flow Metab 2005, In press.
24. Mendelow AD, Gregson BA, Fernandes HM, et al.: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet 2005, 365:387-397.
25. Nakano T, Ohkuma H: Surgery versus conservative treatment for intracerebral haemorrhage - is there an end to the long controversy? Lancet 2005, 365:361-362.
26. Mayer SA, Brun NC, Begtrup K, et al.: Recombinant activated factor vii for acute intracerebral hemorrhage. N Engl J Med 2005, 352:777-785.
27. Qureshi AI, Mohammad YM, Yahia AM, et al.: A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med 2005, 20:34-42.
28. Misra UK, Kalita J, Ranjan P, Mandal SK: Mannitol in intracerebral hemorrhage: A randomized controlled study. J Neurol Sci 2005, 234:41-45.
29. Belayev L, Saul I, Busto R, et al.: Albumin treatment reduces neurological deficit and protects blood-brain barrier Integrity after acute intracortical hematoma in the rat. Stroke 2005, 36:326-331.
30. Lee SL Chu K, Jung KH, et al.: Memantine reduces hematoma expansion in experimental intracerebral hemorrhage, resulting in functional improvement. J Cereb Blood Flow Metab 2005, In press.
31. Wang J, Tsirka SE: Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke 2005, 36:613-618.
32. Nan Z, Grande A, Sanberg CD, et al.: Infusion of human umbilical cord blood ameliorates neurologic deficits In rats with hemorrhagic brain injury. Ann N Y Acad Sci 2005, 1049:84-96.